Encompass Health Corporation $EHC Shares Sold by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. has reduced its stake in Encompass Health Corporation by 7.4%, selling 16,733 shares, and now holds approximately 0.21% of the company's stock valued at $21.36 million.
• Encompass Health recently reported an earnings per share (EPS) of $1.40 for the last quarter, exceeding the consensus estimate of $1.20, along with a 12% increase in revenue year-over-year.
• The company has announced an increase in its quarterly dividend from $0.17 to $0.19 per share, with a dividend yield of 0.6%.

Russell Investments Group Ltd. reduced its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 7.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 210,910 shares of the company's stock after selling 16,733 shares during the period. Russell Investments Group Ltd. owned 0.21% of Encompass Health worth $21,361,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Colonial Trust Co SC purchased a new stake in Encompass Health during the 4th quarter worth approximately $29,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock worth $42,000 after buying an additional 367 shares in the last quarter. Transce3nd LLC purchased a new stake in Encompass Health during the 4th quarter worth approximately $40,000. Arlington Trust Co LLC increased its stake in Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares in the last quarter. Finally, Johnson Financial Group Inc. purchased a new stake in Encompass Health during the 4th quarter worth approximately $72,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Trading Down 0.4%

Encompass Health stock traded down $0.4750 during mid-day trading on Friday, hitting $122.9550. The company's stock had a trading volume of 177,873 shares, compared to its average volume of 812,896. The firm has a market capitalization of $12.38 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 2.16 and a beta of 0.86. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $124.67. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock's fifty day moving average is $116.34 and its two-hundred day moving average is $110.12.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.20. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. Encompass Health's payout ratio is currently 13.31%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Royal Bank Of Canada boosted their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. KeyCorp upped their price target on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a research report on Thursday, June 5th. Finally, Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Buy" and an average price target of $134.00.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.